Status:
RECRUITING
Molecular Signatures in Inflammatory Skin Disease
Lead Sponsor:
Prof. Dr. Stephan Weidinger
Conditions:
Atopic Dermatitis
Psoriasis
Eligibility:
All Genders
Brief Summary
This pilot project intends to examine the utility of a systems medicine approach to identify regulatory networks and their perturbation in psoriasis and atopic dermatitis, and to obtain a comprehensiv...
Detailed Description
This is an exploratory study with the aim to identify molecular profiles and signatures in skin and blood that correlate with inflammatory skin disease, disease activity and disease progression, and t...
Eligibility Criteria
Inclusion
- Ability to provide written informed consent and comply with the protocol
- Dermatologist-diagnosed chronic inflammatory skin disease
- Subject receives systemic therapy within routine care (in-label use of biologics)
Exclusion
- Subject is unable to provide written informed consent or comply with the protocol.
- Having used immunosuppressive/immunomodulating therapy or phototherapy within 4 weeks before the baseline visit.
- Treatment of selected skin areas to be examined with topical corticosteroid or topical calcineurin inhibitor within 1 week before the baseline visit.
Key Trial Info
Start Date :
January 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03358693
Start Date
January 20 2017
End Date
December 31 2029
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel
Kiel, Germany, 24105